内镜下主动脉瓣置换术:孤立与同期手术的初步结果
本研究描述216例患者(114例男性;平均年龄71.3±11.3岁)于2017年5月至2022年10月在一家三级医疗中心接受全内镜下主动脉瓣置换术(AVR)的方法和围术期结果,其中33例(15.2%)行同期手术。孤立AVR的中位手术时间和主动脉阻断时间分别为175分钟(四分位距150-194分钟)和78分钟(四分位距67-92分钟)。30天死亡1例(0.5%),中转开胸2例(0.9%),主要神经事件3例(1.4%),同期手术与否的主要不良事件率相似。结论认为内镜AVR可安全处理同期瓣膜疾病。
要点
- 全内镜下AVR采用3孔技术,主操作孔3-4 cm不撑开肋骨,配合股血管插管。
- 216例中同期手术33例(15.2%),其中21例(63.6%)为二尖瓣手术。
- 孤立AVR中位手术时间175分钟,主动脉阻断时间78分钟。
核心结论
- 内镜AVR可安全处理同期瓣膜疾病。
研究设计与样本
- 单中心描述性研究,纳入2017年5月至2022年10月在一家三级医疗中心接受全内镜下AVR的216例患者(114例男性;平均年龄71.3±11.3岁),比较同期手术与否的围术期结果。
主要发现
- 216例中33例(15.2%)行同期手术,其中21例(63.6%)为二尖瓣手术。
- 165例(76.3%)植入带支架生物瓣,22例(10.2%)植入机械瓣,29例(13.4%)植入快速部署或免缝合瓣。
- 孤立AVR的中位手术时间为175分钟(四分位距150-194分钟),中位主动脉阻断时间为78分钟(四分位距67-92分钟)。
- 30天死亡1例(0.5%),中转开胸2例(0.9%),主要神经事件3例(1.4%)。
- 同期手术与否的主要不良事件率相似。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The applicability of totally endoscopic surgical aortic valve replacement (AVR) in multivalve operations is unknown. This study describes an approach and perioperative outcomes of totally endoscopic isolated and concomitant AVR using various valve types. METHODS: A total of 216 patients (114 male; mean age, 71.3 ± 11.3 years) underwent totally endoscopic AVR from May 2017 to October 2022 in a tertiary care center. The 3-port technique was used: a 3- to 4-cm main port without rib spreading, a 10-mm 3-dimensional endoscopic port, and a 5-mm left-hand port with femoral cannulations. Sutures were hand tied with a knot pusher. Descriptive analyses compared perioperative outcomes between patients with or without concomitant procedures. RESULTS: Of 216 patients, concomitant surgery was performed in 33 (15.2%) patients. Of the 33, 21 (63.6%) had a concomitant mitral procedure. A stented bioprosthesis was implanted in 165 (76.3%) patients, a mechanical valve in 22 (10.2%) patients, and a rapid deployment or sutureless valve in 29 (13.4%) patients. Median operation time and aortic cross-clamp time were 175 minutes (interquartile range; 150-194 minutes) and 78 minutes (interquartile range; 67-92 minutes) for isolated AVR, respectively. Thirty-day mortality occurred in 1 patient (0.5%). Two patients (0.9%) had conversion to sternotomy. Major neurologic events occurred in 3 patients (1.4%). The major adverse event rate was similar between patients with or without concomitant procedures. CONCLUSIONS: Endoscopic AVR can safely address concomitant valve diseases.
引用
- Hosoba S, Ito T, Mori M, et al. Endoscopic Aortic Valve Replacement: Initial Outcomes of Isolated and Concomitant Surgery. Ann Thorac Surg. 2023. PMID: 37276923. doi:10.1016/j.athoracsur.2023.04.045
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。